Ubs Group Ag Qilian International Holding Group LTD Transaction History

Ubs Group Ag

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$0.41 - $0.69 $1,348 - $2,269	-3,289 Reduced 97.97%	68 $0
Q4 2023 Feb 09, 2024	BUY	$0.38 - $0.81 $1,275 - $2,719	3,357 New	3,357 $2,000
Q1 2023 May 12, 2023	SELL	$0.77 - $1.78 $3,021 - $6,984	-3,924 Reduced 68.47%	1,807 $2,000
Q4 2022 Feb 08, 2023	SELL	$0.74 - $6.25 $1,913 - $16,162	-2,586 Reduced 31.09%	5,731 $4,000
Q3 2022 Nov 10, 2022	BUY	$1.14 - $6.1 $4,847 - $25,937	4,252 Added 104.6%	8,317 $10,000
Q2 2022 Aug 10, 2022	BUY	$1.4 - $2.0 $5,691 - $8,130	4,065 New	4,065 $8,000
Q1 2022 May 16, 2022	SELL	$1.57 - $2.68 $131 - $225	-84 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.65 - $4.04 $222 - $339	84 New	84 $0
Q3 2021 Nov 15, 2021	SELL	$3.92 - $4.35 $15,730 - $17,456	-4,013 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$4.13 - $4.9 $13,389 - $15,885	3,242 Added 420.49%	4,013 $17,000
Q1 2021 May 12, 2021	BUY	$4.37 - $12.02 $3,369 - $9,267	771 New	771 $4,000

Ticker QLI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 35,750,000
Market Cap $240M
Description
Qilian International Holding Group Limited engages in the research, development, and production of active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company offers licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Ext...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.